Major Cancer Conferences Reveal Groundbreaking Data from Leading Pharmaceutical Companies
The European Society for Medical Oncology (ESMO) has released data from high-profile presentations several days early due to a broken embargo on the abstracts. The decision was made to ensure fair and equitable access to the data for all relevant parties. The release includes data from Bristol Myers, J&J, Novartis, and AstraZeneca.